OGT is a prominent global provider of clinical and diagnostic genomic solutions, dedicated to enhancing personalized healthcare for patients and empowering clinical researchers in the development of precision medicines. The company focuses on creating innovative products and strategic partnerships that facilitate the delivery of advanced genomic technologies, including FISH and NGS products, across research, clinical, and pharmaceutical markets.